Dr. Joseph Sparano presents new SABCS 2025 findings from a TAILORx biospecimen analysis leading to the development of an AI-based multimodal test (ICM-plus) for ER+/HER2-, node-negative early breast cancer, offering improved long-term prognostic stratification beyond existing genomic assays.
